Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Asensus Surgical
MedTech
Asensus Surgical mulls acquisition offer from Karl Storz
The German medtech staked its claim for Asensus with a deal to buy out all its shares at 35 cents apiece, for a 66.7% premium over its trading price.
Conor Hale
Apr 3, 2024 10:43am
Asensus' Senhance surgical robot labeled with FDA Class I recall
Nov 17, 2023 1:23pm
Asensus lines up digital surgery AI collaboration with Nvidia
Sep 8, 2023 10:16am
Asensus expands its surgical AI vision with European approval
Jan 23, 2023 3:20pm